Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case–control study

Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case–control study

Purpose: To observe the effect of prophylactic intraocular pressure (IOP)-lowering medication (brinzolamide) on IOP after ranibizumab intravitreal injections (IVIs). Materials and Methods: This prospective case–control study included 352 eyes from 352 patients (1 eye per patient) who were treated wi...

Full description

Bibliographic Details
Main Authors:	Shuang Song, Xiao-bing Yu, Hong Dai
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Ophthalmology
Subjects:	Brinzolamide intraocular pressure intravitreal injection ranibizumab
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2016;volume=64;issue=10;spage=762;epage=766;aulast=Song

Similar Items

The Short-Term Effect of Intravitreal Bevacizumab Injection on Intraocular Pressure
by: Şehnaz Özçalışkan, et al.
Published: (2014-10-01)

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a Meta-analysis
by: Cansu Yuksel-Elgin, et al.
Published: (2016-01-01)

Alterations in intraocular pressure and ocular axial length after intravitreal Anti-VEGF injection
by: Hasan Ali Tufan, et al.
Published: (2013-09-01)

Elevation of Intraocular Pressure After Intravitreal Injection of Triamcinolone Acetonide in Taiwanese Patients
by: Yo-Chen Chang, et al.
Published: (2008-02-01)

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration
by: Hisashi Matsubara, et al.
Published: (2016-04-01)

Evaulation of Incidence and Risk Factors for Intraocular Pressure Elevation After Intravitreal Triamcinolone Acetonide Injection
by: Didar Uçar, et al.
Published: (2015-05-01)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
by: Wang N, et al.
Published: (2020-01-01)

Análise da variação da pressão intraocular após injeção intravítrea de ranibizumabe
by: Ignatz Rohrbacher, et al.

Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study
by: Pece A, et al.
Published: (2016-06-01)

Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles
by: Muto T, et al.
Published: (2020-03-01)

Influence of vitreal reflux on intraocular pressure after intravitreal application of bevacizumab
by: Đogatović Nebojša, et al.
Published: (2020-01-01)

Apraclonidine versus brinzolamide-timolol combination to prevent intraocular pressure elevation after laser capsulotomy
by: Erkan Çelik, et al.
Published: (2016-01-01)

Acute endophthalmitis caused by Enterococcus faecalis following intravitreal ranibizumab injection
by: Ram Sudarshan Ravindran, et al.
Published: (2020-01-01)

Short-term effects and safety of an acute increase of intraocular pressure after intravitreal bevacizumab injection on corneal endothelial cells
by: Jiwoong Park, et al.
Published: (2018-01-01)

Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
by: Young Gun Park, et al.
Published: (2015-04-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Multiple Intravitreal Ranibizumab Injections for Persistant Choroidal Neovascularization Associated with Presumed Ocular Histoplasmosis Syndrome
by: Turgut Yılmaz, et al.
Published: (2017-03-01)

Intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
by: Amr Abdel-Fattah Ali Gab-Alla
Published: (2015-01-01)

Effect of 1% brinzolamide and 0.5% timolol fixed combination on intraocular pressure after cataract surgery with phacoemulsification
by: Kemal Örnek, et al.
Published: (2013-12-01)

Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
by: Masahiro Onda, et al.
Published: (2019-01-01)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Comparison between two intravitreal injection techniques with respect to fluid reflux, intraocular pressure, and therapeutic effect
by: Shashi Tanwar, et al.
Published: (2021-01-01)

Anterior infectious necrotizing scleritis secondary to Pseudomonas aeruginosa infection following intravitreal ranibizumab injection
by: Razek Georges Coussa, et al.
Published: (2017-04-01)

Comparison of curative effects of intravitreal injection of Ranibizumab and Conbercept in the treatment of diabetic macular edema
by: Yang Guo, et al.
Published: (2018-01-01)

Complications of intravitreal triamcinolone acetonide for macular edema and predictive factors for intraocular pressure elevation
by: Kenan Sonmez, et al.
Published: (2012-12-01)

Application of the intravitreal Ranibizumab combined with retinal photocoagulation for the neovascular glaucoma
by: Fen-Dui Zhang, et al.
Published: (2015-05-01)

Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion
by: Jing-Yi Lai, et al.
Published: (2016-04-01)

Effects of brinzolamide on rabbit ocular blood flow in vivo and ex vivo
by: Ya-Ru Dong, et al.
Published: (2018-05-01)

Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
by: Austin Bach, et al.
Published: (2017-12-01)

Efficacy of intravitreal injection of ranibizumab in the treatment of macular edema secondary to non-ischemic branch retinal vein occlusion
by: Jue Liu, et al.
Published: (2020-01-01)

Effects of Intravitreal Injection of Ranibizumab and Aflibercept on Corneal Endothelium and Central Corneal Thickness
by: Mehmet Coskun
Published: (2018-08-01)

Treatment and prevention of intraocular pressure increase after ophthalmic surgeries
by: A. A. Antonov, et al.
Published: (2018-12-01)

Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
by: Olga Furashova, et al.
Published: (2020-07-01)

Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System
by: Fazhan Wang, et al.
Published: (2018-02-01)

Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure:a comparative clinical study
by: Gökhan Özge, et al.
Published: (2013-04-01)

Intravitreal Ranibizumab for Diabetic Macular Edema Patients with Good Baseline Visual Acuity: A Real-Life Study
by: Abdullah Ozkaya, et al.
Published: (2017-10-01)

Risk of elevated intraocular pressure after ranibizumab injection in patients with neovascular age-related macular degeneration
by: Moghadaszadeh, Solmaz
Published: (2017)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
by: Carlos Menezes, et al.
Published: (2015-06-01)

Intravitreal injection of Ranibizumab combined with laser photocoagulation for macular edema secondary to BRVO
by: Guo-Ping Wang, et al.
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_d1pb0u70r56ap9g23471084k6g